Central prostate pathology review: Should it be mandatory?

European Urology

Volumn 64, Issue 2, 2013, Pages 199-201

  Montironi, Rodolfo ^a   Lopez Beltran, Antonio ^b   Cheng, Liang ^c   Montorsi, Francesco ^d   Scarpelli, Marina ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; GLEASON SCORE; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATECTOMY; REVIEW;

EID: 84879935168     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.04.002     Document Type: Editorial

References (18)

1. F. Brimo, L. Schultz, and J.I. Epstein The value of mandatory second opinion pathology review of prostate needle biopsy interpretation before radical prostatectomy J Urol 184 2010 126 130
2. D. Bottke, R. Golz, and S. Störkel Phase 3 study of adjuvant radiotherapy versus wait and see in pT3 prostate cancer: impact of pathology review on analysis Eur Urol 64 2013 193 198
3. C. Selli, R. Montironi, A. Bono PROSIT Study Group Effects of complete androgen blockade for 12 and 24 weeks on the pathological stage and resection margin status of prostate cancer J Clin Pathol 55 2002 508 513
4. T.H. van der Kwast, L. Collette, and H. Van Poppel Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911) Virchows Arch 449 2006 428 434
5. G.J. Netto, M. Eisenberger, and J.I. Epstein Interobserver variability in histologic evaluation of radical prostatectomy between central and local pathologists: findings of TAX 3501 multinational clinical trial Urology 77 2011 1155 1157
6. D.F. Gleason Classification of prostatic carcinomas Cancer Chemother Rep 50 1966 125 128
7. L. Egevad, R. Mazzucchelli, and R. Montironi Implications of the International Society of Urological Pathology modified Gleason grading system Arch Pathol Lab Med 136 2012 426 434
8. J.I. Epstein, W.C. Allsbrook Jr., M.B. Amin, L.L. Egevad ISUP Grading Committee The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Am J Surg Pathol 29 2005 1228 1242
9. B. Helpap, and L. Egevad The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens Virchows Arch 449 2006 622 627
10. S.W. Fine, and J.I. Epstein A contemporary study correlating prostate needle biopsy and radical prostatectomy Gleason score J Urol 179 2008 1335 1338
11. D.M. Steinberg, J. Sauvageot, S. Piantadosi, and J.I. Epstein Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings Am J Surg Pathol 21 1997 566 576
12. J.I. Epstein An update of the Gleason grading system J Urol 183 2010 433 440
13. T.L. Lotan, and J.I. Epstein Gleason grading of prostatic adenocarcinoma with glomeruloid features on needle biopsy Hum Pathol 40 2009 471 477
14. H.B. Carter, A.W. Partin, and P.C. Walsh Gleason score 6 adenocarcinoma: should it be labeled as cancer? J Clin Oncol 30 2012 4294 4296
15. R. Montironi, L. Cheng, and A. Lopez-Beltran Original Gleason system versus 2005 ISUP modified Gleason system: the importance of indicating which system is used in the patient's pathology and clinical reports Eur Urol 58 2010 369 373
16. J.K. McKenney, J. Simko, M. Bonham Canary/Early Detection Research Network Prostate Active Surveillance Study Investigators The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional study J Urol 186 2011 465 469
17. L. Egevad, A.S. Ahmad, and F. Algaba Standardization of Gleason grading among 337 European pathologists Histopathology 62 2013 247 256
18. N. D'Souza, D.A. Loblaw, A. Mamedov, L. Sugar, and L. Holden Prostate cancer pathology audits: is central pathology review still warranted? Can J Urol 19 2012 6256 6260